BiotechTube
Home/Valneva/Franck Grimaud
FG

Franck Grimaud

Chief Business Officer

Valneva

Therapeutic Areas

Infectious DiseasesTravel Health

Valneva Pipeline

DrugIndicationPhase
VLA15Lyme DiseasePhase 3
IXCHIQ (VLA1553)ChikungunyaMarketed
Shigella Vaccine CandidateShigellosisPhase 2
Zika Vaccine CandidateZika VirusPhase 2

Leadership Team at Valneva

TL
Thomas Lingelbach
Chief Executive Officer
PB
Peter Bühler
Chief Financial Officer
JC
Juan Carlos Jaramillo, M.D.
Chief Medical Officer
FJ
Frédéric Jacotot
Chief Technical Operations Officer
J(
James (Jim) F. Cummings
General Counsel
View full Valneva profile